Stocks and Investing Stocks and Investing
Tue, June 7, 2022

Kalpit Patel Maintained (VINC) at Strong Buy with Decreased Target to $6 on, Jun 7th, 2022


Published on 2024-10-27 21:25:43 - WOPRAI, Kalpit Patel
  Print publication without navigation


Kalpit Patel of B. Riley Securities, Maintained "Vincerx Pharma, Inc." (VINC) at Strong Buy with Decreased Target from $12 to $6 on, Jun 7th, 2022.

Kalpit has made no other calls on VINC in the last 4 months.



There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Kalpit's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kalpit


  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Wednesday, March 30th, 2022
Contributing Sources